Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) Stock Suddenly Jumps 24%: What’s The Buzz?

February 3, 2022

Those who are looking into the stocks which rallied strongly on Wednesday must have come across the gains that were generated by the Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) stock. It was one of the more notable movers yesterday and ended the day with gains of as much as 24%. Trading Data On Wednesday, ETTX stock soared 24.14% to $1.80 with more than 10.20 million shares, compared to its average volume…

Read More >>

Nasdaq Stocks On The Run: LYL, ETTX, AGRI, XCUR, EPZM

February 3, 2022

Following were the most active stock runners on Wednesday. Traders may keep a eye on these stocks as momentum may continue consider high volume activities. Viking Energy Group (OTCMKTS:VKIN) has acquired ESG Clean Systems technology that captures the carbon emissions from combustion engines and converts it into sellable commodities.  This is a novel solution because it adds revenue streams ontop of it’s positive environmental effect.  VKIN is diversified in the…

Read More >>

Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) Announces New Chief Commercial Officer

July 15, 2021

Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) announced recently that Anna Diaz Triola is appointed as the company’s Chief Commercial Officer. He assumed responsibilities with effect from July 19, 2021. The clinical-stage biopharmaceutical company develops and discovers antibacterial products. In his new position, Anna Diaz Triola will be responsible for commercial strategy, driving it for marketing and sales operations for the U.SUS.  Gearing up for product commercialization  The company is in…

Read More >>